Difference between revisions of "Patrick Machado"
From QueerBio.com
Line 19: | Line 19: | ||
* [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | ||
− | * [[ | + | * [[Noteworthy LGBTQ Individuals in the Accounting Profession]] |
==Further Reading/Research== | ==Further Reading/Research== |
Latest revision as of 14:48, 5 August 2024
Country
Australia
Birth - Death
Occupation
Business
Description
Member of the Board of Directors of Prota Therapeutics, Alumis, Acelyrin, Xenon Pharmaceuticals, and many other pharmaceutical and biotherapeutic companies. Co-founded and served as Chief Financial Officer and Chief Business Officer at Medivation, Inc. until his retirement in 2014 and served as a member of Medivation’s board of directors from 2014 until its acquisition for approximately $14 billion by Pfizer in 2016. Lawyer.
See Also
- LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies
- Noteworthy LGBTQ Individuals in the Accounting Profession